1.1. Aortic diseases Since the 1960s, Zhongshan Hospital of Fudan University (Shanghai Zhongshan Hospital) has performed 650 cases of abdominal aortic aneurysm (AAA) resection and artificial vessel transplantation, with a total operative mortality rate of 5.2%, a 5-year survival rate of 74.4%, and a 10-year survival rate of 69.9% [1], which is similar to the statistics of foreign countries. On the basis of mastering the classical traditional surgery, domestic scholars follow the world trend of “endoluminal” in vascular surgery. Minimally invasive” development trend, in 1997 and 1998 respectively, began the endoluminal treatment of abdominal aorta and thoracic aorta diseases. In fact, it has been impossible to discuss any problem in vascular surgery without mentioning endoluminal treatment. In less than a decade, the number of cases has increased significantly, with Stanford type B coarctation aneurysms, for example, being treated in large samples at Changhai Hospital of the Second Military Medical University, Zhongshan Hospital of Fudan University, and the General Hospital of the Chinese People’s Liberation Army since 2000 [2-4]. Endoluminal therapy has become one of the conventional methods for the treatment of aortic disease, and is often preferred, especially in patients of advanced age and with many comorbidities. Currently, the hotspots and difficulties in the treatment of aortic disease are focused on expanding the indications for endoluminal therapy and the prevention and treatment of its complications. In China, the incidence of coarctation aneurysms is much higher than that of true aneurysms of the thoracic aorta. The majority of patients treated intraluminally in the thoracic aorta are Stanford type B coarctation aneurysms, and the most common primary fissure is located in the distal part of the aortic isthmus, the left subclavian artery, and the distance between them, the proximal anchorage zone, is mostly.